By Josh White
Date: Friday 17 May 2019
LONDON (ShareCast) - (Sharecast News) - First Derivatives announced on Friday that its chief executive officer Brian Conlon has recently been diagnosed with cancer.
The AIM-traded firm said Conlon would remain at his post during his ongoing weekly treatment, which included chemotherapy.
It said the treatment was expected to last a number of months.
\"The board has set a clear strategy and the executive committee, led by Brian, has delivered strong execution of that strategy year-on-year,\" said First Derivatives chairman Seamus Keating.
\"During the period of his treatment I will provide additional executive and governance support and I am confident that Brian and his team will continue to execute the group\'s growth plans successfully.\"
Email this article to a friend
or share it with one of these popular networks: